MUFG Securities EMEA’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.7M Buy
695,043
+634,258
+1,043% +$34.4M 0.31% 65
2026
Q1
$3.81M Sell
60,785
-278,642
-82% -$22.3M 0.06% 201
2025
Q4
$32.4M Buy
339,427
+311,065
+1,097% +$30.5M 0.38% 58
2025
Q3
$2.77M Buy
28,362
+23,990
+549% +$2.48M 0.07% 137
2025
Q2
$470K Buy
+4,372
New +$442K 0.02% 136
2021
Q2
Sell
-1,049,318
Closed -$40.6M 312
2021
Q1
$40.6M Buy
1,049,318
+522,000
+99% +$19.8M 0.33% 69
2020
Q4
$19M Buy
527,318
+274,000
+108% +$9.88M 0.14% 113
2020
Q3
$9.68M Sell
253,318
-95,682
-27% -$3.69M 0.09% 142
2020
Q2
$12.3M Sell
349,000
-231,750
-40% -$8.35M 0.11% 140
2020
Q1
$18.9M Buy
580,750
+41,750
+8% +$1.63M 0.19% 95
2019
Q4
$24.4M Buy
+539,000
New +$22.6M 0.19% 106
2018
Q4
Sell
-37,490
Closed -$1.44M 448
2018
Q3
$1.44M Buy
37,490
+35,944
+2,325% +$1.26M 0.02% 274
2018
Q2
$51K Buy
+1,546
New +$46.6K ﹤0.01% 295

Other funds holding BSX

MUFG Securities EMEA's BSX Position: Q2 2026 in Review

MUFG Securities EMEA increased its Boston Scientific (BSX) stake by 1,043% in Q2 2026, buying an estimated $34.4M and bringing the position to 695,043 shares worth $29.7M. The position accounts for 0.31% of the portfolio, ranked #65.

MUFG Securities EMEA first reported a position in BSX in Q2 2018 and has held it in 13 quarters since. The position peaked at $40.6M in Q1 2021. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • MUFG Securities EMEA held 695,043 shares of Boston Scientific worth $29.7M as of Q2 2026.
  • MUFG Securities EMEA bought 634,258 Boston Scientific shares in Q2 2026, an estimated $34.4M.
  • Boston Scientific made up 0.31% of MUFG Securities EMEA's portfolio in Q2 2026, its #65 holding.
  • MUFG Securities EMEA first reported a position in Boston Scientific in Q2 2018 and has held it in 13 quarters since.
  • MUFG Securities EMEA's Boston Scientific position peaked at $40.6M in Q1 2021.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.